Oatly Group AB Sponsored ADR (NASDAQ:OTLY) Receives Consensus Rating of “Hold” from Analysts

Shares of Oatly Group AB Sponsored ADR (NASDAQ:OTLY) have received an average rating of “Hold” from the seven ratings firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $14.70.

A number of analysts have recently commented on OTLY shares. Morgan Stanley set a $14.50 price target on Oatly Group in a research note on Tuesday, February 17th. Barclays set a $15.00 price objective on shares of Oatly Group and gave the stock an “overweight” rating in a research note on Friday, January 16th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Oatly Group in a research note on Friday, March 27th. Finally, Zacks Research upgraded shares of Oatly Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 17th.

Oatly Group Stock Performance

OTLY stock opened at $10.20 on Thursday. Oatly Group has a twelve month low of $8.35 and a twelve month high of $18.84. The company has a quick ratio of 0.35, a current ratio of 0.48 and a debt-to-equity ratio of 10.55. The company has a market cap of $318.55 million, a P/E ratio of -1.99 and a beta of 1.94. The business’s fifty day moving average is $11.03 and its 200-day moving average is $12.59.

Oatly Group (NASDAQ:OTLY) last released its quarterly earnings data on Wednesday, February 11th. The company reported ($0.61) EPS for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.07). Oatly Group had a negative net margin of 17.71% and a negative return on equity of 236.71%. The company had revenue of $233.78 million during the quarter, compared to the consensus estimate of $216.05 million. Equities research analysts forecast that Oatly Group will post -3.2 EPS for the current year.

Institutional Trading of Oatly Group

Several hedge funds have recently added to or reduced their stakes in OTLY. Performa Ltd US LLC grew its stake in Oatly Group by 16.8% in the fourth quarter. Performa Ltd US LLC now owns 10,100 shares of the company’s stock valued at $108,000 after acquiring an additional 1,450 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Oatly Group by 9.5% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,130 shares of the company’s stock worth $215,000 after purchasing an additional 1,568 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Oatly Group by 19.0% during the 3rd quarter. Van ECK Associates Corp now owns 11,001 shares of the company’s stock valued at $178,000 after purchasing an additional 1,756 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Oatly Group by 62.2% in the 3rd quarter. GAMMA Investing LLC now owns 5,194 shares of the company’s stock valued at $84,000 after purchasing an additional 1,991 shares during the period. Finally, UBS Group AG grew its position in shares of Oatly Group by 1.5% in the 3rd quarter. UBS Group AG now owns 646,591 shares of the company’s stock valued at $10,475,000 after purchasing an additional 9,620 shares during the period. Institutional investors and hedge funds own 68.15% of the company’s stock.

About Oatly Group

Oatly Group is a Sweden-based food and beverage company specializing in the development, production and sale of oat-derived dairy alternatives. The company’s product lineup includes oat-based drinks, ice cream, yogurts, spreads and cooking creams, all marketed under the Oatly brand name. By leveraging proprietary processing technology, Oatly extracts the nutritional benefits of oats—such as soluble fiber and plant protein—while delivering taste and texture profiles that closely mimic traditional dairy products.

Founded in 1994 as a spin-off from research at Lund University, Oatly initially focused on exploiting the health and functional benefits of oat beta-glucans.